Characterizing Smartphone Engagement for Schizophrenia: Results of a Naturalist Mobile Health Study.

John Torous, Patrick Staples, Linda Slaters, Jared Adams, Luis Sandoval, J P Onnela, Matcheri Keshavan
{"title":"Characterizing Smartphone Engagement for Schizophrenia: Results of a Naturalist Mobile Health Study.","authors":"John Torous, Patrick Staples, Linda Slaters, Jared Adams, Luis Sandoval, J P Onnela, Matcheri Keshavan","doi":"10.3371/CSRP.JTPS.071317","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite growing interest in smartphone apps for schizophrenia, little is known about how these apps are utilized in the real world. Understanding how app users are engaging with these tools outside of the confines of traditional clinical studies offers an important information on who is most likely to use apps and what type of data they are willing to share.</p><p><strong>Methods: </strong>The Schizophrenia and Related Disorders Alliance of America, in partnership with Self Care Catalyst, has created a smartphone app for schizophrenia that is free and publically available on both Apple iTunes and Google Android Play stores. We analyzed user engagement data from this app across its medication tracking, mood tracking, and symptom tracking features from August 16<sup>th</sup> 2015 to January 1<sup>st</sup> 2017 using the R programming language. We included all registered app users in our analysis with reported ages less than 100.</p><p><strong>Results: </strong>We analyzed a total of 43,451 mood, medication and symptom entries from 622 registered users, and excluded a single patient with a reported age of 114. Seventy one percent of the 622 users tried the mood-tracking feature at least once, 49% the symptom tracking feature, and 36% the medication-tracking feature. The mean number of uses of the mood feature was two, the symptom feature 10, and the medication feature 14. However, a small subset of users were very engaged with the app and the top 10 users for each feature accounted for 35% or greater of all entries for that feature. We find that user engagement follows a power law distribution for each feature, and this fit was largely invariant when stratifying for age or gender.</p><p><strong>Discussion: </strong>Engagement with this app for schizophrenia was overall low, but similar to prior naturalistic studies for mental health app use in other diseases. The low rate of engagement in naturalistic settings, compared to higher rates of use in clinical studies, suggests the importance of clinical involvement as one factor in driving engagement for mental health apps. Power law relationships suggest strongly skewed user engagement, with a small subset of users accounting for the majority of substantial engagements. There is a need for further research on app engagement in schizophrenia.</p>","PeriodicalId":40019,"journal":{"name":"Clinical Schizophrenia and Related Psychoses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Schizophrenia and Related Psychoses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3371/CSRP.JTPS.071317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Despite growing interest in smartphone apps for schizophrenia, little is known about how these apps are utilized in the real world. Understanding how app users are engaging with these tools outside of the confines of traditional clinical studies offers an important information on who is most likely to use apps and what type of data they are willing to share.

Methods: The Schizophrenia and Related Disorders Alliance of America, in partnership with Self Care Catalyst, has created a smartphone app for schizophrenia that is free and publically available on both Apple iTunes and Google Android Play stores. We analyzed user engagement data from this app across its medication tracking, mood tracking, and symptom tracking features from August 16th 2015 to January 1st 2017 using the R programming language. We included all registered app users in our analysis with reported ages less than 100.

Results: We analyzed a total of 43,451 mood, medication and symptom entries from 622 registered users, and excluded a single patient with a reported age of 114. Seventy one percent of the 622 users tried the mood-tracking feature at least once, 49% the symptom tracking feature, and 36% the medication-tracking feature. The mean number of uses of the mood feature was two, the symptom feature 10, and the medication feature 14. However, a small subset of users were very engaged with the app and the top 10 users for each feature accounted for 35% or greater of all entries for that feature. We find that user engagement follows a power law distribution for each feature, and this fit was largely invariant when stratifying for age or gender.

Discussion: Engagement with this app for schizophrenia was overall low, but similar to prior naturalistic studies for mental health app use in other diseases. The low rate of engagement in naturalistic settings, compared to higher rates of use in clinical studies, suggests the importance of clinical involvement as one factor in driving engagement for mental health apps. Power law relationships suggest strongly skewed user engagement, with a small subset of users accounting for the majority of substantial engagements. There is a need for further research on app engagement in schizophrenia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
智能手机参与精神分裂症治疗的特征:自然主义移动健康研究的结果
导言:尽管人们对治疗精神分裂症的智能手机应用程序越来越感兴趣,但对这些应用程序在现实世界中的使用情况却知之甚少。在传统的临床研究之外,了解应用程序用户如何使用这些工具,对于了解谁最有可能使用应用程序以及他们愿意分享哪类数据具有重要意义:美国精神分裂症及相关疾病联盟(Schizophrenia and Related Disorders Alliance of America)与 "自我护理催化剂"(Self Care Catalyst)合作开发了一款针对精神分裂症的智能手机应用程序,该应用程序免费并可在苹果 iTunes 和谷歌 Android Play 商店公开下载。我们使用 R 编程语言分析了 2015 年 8 月 16 日至 2017 年 1 月 1 日期间该应用程序的用户参与数据,包括药物跟踪、情绪跟踪和症状跟踪功能。我们将报告年龄小于 100 岁的所有注册应用程序用户都纳入了分析范围:我们分析了来自 622 名注册用户的共计 43451 项情绪、药物和症状条目,并排除了一名报告年龄为 114 岁的患者。在 622 名用户中,71% 的用户至少尝试过一次情绪跟踪功能,49% 的用户尝试过症状跟踪功能,36% 的用户尝试过药物跟踪功能。情绪功能的平均使用次数为 2 次,症状功能为 10 次,药物功能为 14 次。然而,有一小部分用户对该应用的参与度非常高,每个功能的前 10 名用户占该功能所有使用次数的 35% 或更多。我们发现,每个功能的用户参与度都呈幂律分布,而且在根据年龄或性别进行分层时,这种拟合基本不变:这款精神分裂症应用程序的用户参与度总体较低,但与之前针对其他疾病的心理健康应用程序使用情况进行的自然研究结果相似。与临床研究中较高的使用率相比,自然环境中的参与率较低,这表明临床参与是推动心理健康应用程序参与的一个重要因素。幂律关系表明,用户的参与度有很大的偏差,一小部分用户占据了大部分的实质性参与度。有必要进一步研究精神分裂症患者对应用程序的使用情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Schizophrenia and Related Psychoses
Clinical Schizophrenia and Related Psychoses Medicine-Psychiatry and Mental Health
自引率
0.00%
发文量
0
期刊介绍: The vision of the exciting new peer-reviewed quarterly publication Clinical Schizophrenia & Related Psychoses (CS) is to provide psychiatrists and other healthcare professionals with the latest research and advances in the diagnosis and treatment of schizophrenia and related psychoses. CS is a practice-oriented publication focused exclusively on the newest research findings, guidelines, treatment protocols, and clinical trials relevant to patient care.
期刊最新文献
Dysexecutive Behavior in First-Episode Schizophrenia. Dysexecutive Behavior in First-Episode Schizophrenia Grading meningiomas by used imaging features on magnetic resonance imaging The Association between Serum Levels of Ferritin and D-Dimer with Liver Function Tests in Patients with COVID-19 Role of Susceptibility Weighted Magnetic Resonance Imaging in Neurological Diagnosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1